{
    "address": "Medicon Village, Scheelevagen 2",
    "city": "Lund",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W4300F100",
    "description": "Immunovia AB engages in the development of methods for diagnosing complex forms of cancer and autoimmune diseases. The company is headquartered in Lund, Skane and currently employs 69 full-time employees. The company went IPO on 2015-12-01. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.",
    "employeeTotal": "69.0",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Health Care",
    "ggroup": "Health Care Equipment & Services",
    "gind": "Health Care Equipment & Supplies",
    "gsector": "Health Care",
    "gsubind": "Health Care Equipment",
    "ipo": "2015-12-01",
    "isin": "SE0006091997",
    "logo": "https://finnhub.io/api/logo?symbol=IMMNOV.ST",
    "marketCapitalization": 2067.395,
    "naics": "Scientific Research and Development Services",
    "naicsNationalIndustry": "Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)",
    "naicsSector": "Professional, Scientific, and Technical Services",
    "naicsSubsector": "Professional, Scientific, and Technical Services",
    "name": "Immunovia AB (publ)",
    "phone": "46462756000.0",
    "sedol": "BYZ1X84",
    "shareOutstanding": 22.631581,
    "state": "SKANE",
    "ticker": "IMMNOV.ST",
    "weburl": "http://immunovia.com"
}